[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.180.70. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
August 1964

Radioactive Isotopes for Adjuvant Cancer TherapyAnimal Experimentation and Preliminary Results in Human Application

Author Affiliations

NEW YORK
From the Soft Somatic Tumor Service, Hospital for Joint Disease, and the Pack Medical Foundation.

Arch Surg. 1964;89(2):244-249. doi:10.1001/archsurg.1964.01320020008002
Abstract

Introduction  The most frequent reason for failure to cure most cancers is the vascular spread of the tumor. The two organs to which metastases most frequently occur are the liver and the lungs. Attempts to prevent the "take" of the tumor emboli in these organs or to discourage their growth once they have lodged in these organs have been made by Dr. Warren H. Cole and his associates, utilizing chemotherapeutic agents. They have demonstrated that certain chemotherapeutic agents, administered at the same time that tumor inocula are introduced into experimental animals, exert an influence in discouraging the "take" or growth of such neoplasms. At the clinical level such efforts have been discouraging. A nationwide study in which chemotherapeutic adjuvant theray was administered at the time curative resections were performed for cancers of the lung, stomach, rectum, and breast revealed no beneficial effects for the first three, but a possible beneficial

First Page Preview View Large
First page PDF preview
First page PDF preview
×